CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

4.390 -0.010 (-0.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist

Price and Volume

Volume	1,394,881
Open	4.430
Bid (Size)	4.320 (100)
Ask (Size)	4.480 (1,200)
Prev. Close	4.400
Today's Range	4.265 - 4.480
52wk Range	0.4000 - 4.620
Shares Outstanding	66,767,779
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CytomX Therapeutics Inc (NASDAQ:CTMX) Reports Q3 2025 Earnings Miss, Stock Falls ↗

November 06, 2025

CytomX Therapeutics Q3 2025 earnings miss analyst estimates for revenue and EPS, triggering a negative market reaction.

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Performance

YTD	+314.2%	+314.2%
1 Month	+5.8%	+5.8%
3 Month	+54.6%	+54.6%
6 Month	+90.0%	+90.0%
1 Year	+288.5%	+288.5%

More News

CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

October 21, 2025

Via Benzinga

Why CytomX Therapeutics Stock Was Skyrocketing This Week ↗

September 26, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 25, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

What's going on in today's after hours session ↗

September 25, 2025

Via Chartmill

Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket ↗

August 26, 2025

Via Benzinga

Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

August 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 12, 2025

Via Benzinga

CytomX (CTMX) Q2 Revenue Drops 26% ↗

August 07, 2025

Via The Motley Fool

CytomX Therapeutics Inc (NASDAQ:CTMX) Reports Q2 2025 Revenue Beat and Break-Even EPS ↗

August 07, 2025

Via Chartmill

This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday ↗

July 31, 2025

Via Benzinga

Deep Dive Into CytomX Therapeutics Stock: Analyst Perspectives (4 Ratings) ↗

July 31, 2025

Via Benzinga

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

Via Investor Brand Network

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

Via FinancialNewsMedia

CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - A Strong Contender in High-Growth Biotech ↗

July 08, 2025

Via Chartmill

Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday ↗

May 28, 2025

Via Benzinga

CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

May 20, 2025

Via Benzinga

This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday ↗

May 15, 2025

Via Benzinga

CytomX Stock Hits 2-Month High After Upbeat Q1 Earnings, Promising Early Data For Cancer Drug ↗

May 12, 2025

Via Stocktwits

Top movers analysis one hour before the close of the markets on 2025-05-12: top gainers and losers in today's session. ↗

May 12, 2025

Via Chartmill

Monday's session: most active stocks ↗

May 12, 2025

Via Chartmill

Stocks Under $1 to Watch: TAOP, WLGS, HIT, CTMX, JYD – Major Updates, Earnings & Offerings, More Inside….

May 12, 2025

Via AB Newswire

Which stocks are moving on Monday? ↗

May 12, 2025

Via Chartmill

Frequently Asked Questions

Is CytomX Therapeutics, Inc. - Common Stock publicly traded?

Yes, CytomX Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does CytomX Therapeutics, Inc. - Common Stock trade on?

CytomX Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for CytomX Therapeutics, Inc. - Common Stock?

The ticker symbol for CytomX Therapeutics, Inc. - Common Stock is CTMX on the Nasdaq Stock Market

What is the current price of CytomX Therapeutics, Inc. - Common Stock?

The current price of CytomX Therapeutics, Inc. - Common Stock is 4.390

When was CytomX Therapeutics, Inc. - Common Stock last traded?

The last trade of CytomX Therapeutics, Inc. - Common Stock was at 12/26/25 04:00 PM ET

What is the market capitalization of CytomX Therapeutics, Inc. - Common Stock?

The market capitalization of CytomX Therapeutics, Inc. - Common Stock is 293.11M

How many shares of CytomX Therapeutics, Inc. - Common Stock are outstanding?

CytomX Therapeutics, Inc. - Common Stock has 293M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.